Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?

被引：13

作者：

Hawkey, CJ ^{[1
]}

机构：

[1] Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2000年 / 321卷 / 7256期

关键词：

D O I：

10.1136/bmj.321.7256.291

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：291 / 293

页数：3

相关论文

共 30 条

[1] [Anonymous], 1986, LANCET, V2, P57
[2] Boyce EG, 1999, FORMULARY, V34, P405
[3] Eradication of H-pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users:: A prospective randomized study.
Chan, FKL
Sung, JY
Suen, R
Lee, YT
Leung, WK
Leung, VKS
Wu, JCY
Chung, CS
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A87 - A87
[4] EFFICACY OF 12 MONTHS MISOPROSTOL AS PROPHYLAXIS AGAINST NSAID-INDUCED GASTRIC-ULCERS - A PLACEBO-CONTROLLED TRIAL
ELLIOTT, SL
YEOMANS, ND
BUCHANAN, RRC
SMALLWOOD, RA
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (04) : 171 - 176
[5] Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
Emery, P
Zeidler, H
Kvien, TK
Guslandi, M
Naudin, R
Stead, H
Verburg, KM
Isakson, PC
Hubbard, RC
Geis, GS
[J]. LANCET, 1999, 354 (9196) : 2106 - 2111
[6] GOLDSTEIN JL, 1999, GASTROENTEROLOGY, V116, pA17
[7] GRAHAM DY, 1988, LANCET, V2, P1277
[8] DUODENAL AND GASTRIC-ULCER PREVENTION WITH MISOPROSTOL IN ARTHRITIS PATIENTS TAKING NSAIDS
GRAHAM, DY
WHITE, RH
MORELAND, LW
SCHUBERT, TT
KATZ, R
JASZEWSKI, R
TINDALL, E
TRIADAFILOPOULOS, G
STROMATT, SC
TEOH, LS
[J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (04) : 257 - 262
[9] *GROUP ISIS 4, 1994, LANCET, V343, P115
[10] Hawkey C, 1998, BRIT J RHEUMATOL, V37, P937